Leila Alland - 09 Sep 2022 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
Chief Medical Officer
Signature
/s/ Winston Kung, by power of attorney
Issuer symbol
PMVP
Transactions as of
09 Sep 2022
Net transactions value
$0
Form type
4
Filing time
13 Sep 2022, 16:23:15 UTC
Previous filing
28 Feb 2022
Next filing
28 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PMVP Common Stock Award $0 +52,200 $0.000000 52,200 09 Sep 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares are represented by restricted stock units, or RSUS. One- third of the RSUs vest on September 9, 2023 and the remaining shares vest on September 9, 2024.